Stifel Upgrades Editas Medicine (EDIT) to Buy, 'Difficult To Justify Current Valuation'

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/9/2026

1. USO
2. MSFT
3. SPY
4. META
5. COST
6. MU
7. CME
8. RMR
9. LEVI
10. RXT

Go back to Stifel Upgrades Editas Medicine (EDIT) to Buy, 'Difficult To Justify Current Valuation'
(NASDAQ: EDIT) Delayed: 3.60 -0.07 (1.91%)
Previous Close $3.67    52 Week High $43.99 
Open $3.65    52 Week Low $12.43 
Day High $3.72    P/E N/A 
Day Low $3.52    EPS $0.00 
Volume 504,931